You should read the following discussion and analysis in conjunction with our financial statements, including the notes thereto contained in this Annual Report. This discussion contains... | April 17, 2023
Source: marketscreener.com
Page 22 - Development Expense News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Development Expense. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Development Expense Today - Breaking & Trending Today
Unless the context otherwise requires, all references in this section to the Company, we, us, or our refer to the business of Navitas and its subsidiaries. Throughout this section, unless otherwise... | April 3, 2023
Source: marketscreener.com
SCYNEXIS : 10-K Filing | MarketScreener
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ... | March 31, 2023
Source: marketscreener.com
Vivani Medical Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
Vivani Medical, Inc. (Nasdaq: VANI) (“Vivani” or the “Company”), a biopharmaceutical company developing miniaturized, long-term drug implants, including lead product candidate NPM-119 for the treatment of patients with type 2 diab...
Source: marketscreener.com
Forward-Looking Statements In addition to historical information, the following Management's Discussion and Analysis of Financial Condition and Results of Operations contains forward-looking... | March 30, 2023
Source: marketscreener.com